COVID-19 and gendered governance: countries led by women did not employ more stringent strategies than those led by men – but they did act faster

Mette Marie Staehr Harder and Christoffer Bugge Harder examine whether countries led by women applied more extensive measures to combat COVID-19 than those led by men. While they find no indications that the former applied more extensive health responses over time, OECD countries led by women did enact their respective maximum shutdown measures significantly more quickly than those led by men

Local diversity of heathland Cercozoa explored by in-depth sequencing

Cercozoa are abundant free-living soil protozoa and quantitatively important in soil food webs; yet, targeted high-throughput sequencing (HTS) has not yet been applied to this group. Here we describe the development of a targeted assay to explore Cercozoa using HTS, and we apply this assay to measure Cercozoan community response to drought in a Danish climate manipulation experiment (two sites exposed to artificial drought, two unexposed). Based on a comparison of the hypervariable regions of the 18S ribosomal DNA of 193 named Cercozoa, we concluded that the V4 region is the most suitable for group-specific diversity analysis. We then designed a set of highly specific primers (encompassing ~270 bp) for 454 sequencing. The primers captured all major cercozoan groups; and >95% of the obtained sequences were from Cercozoa. From 443 350 high-quality short reads (>300 bp), we recovered 1585 operational taxonomic units defined by >95% V4 sequence similarity. Taxonomic annotation by phylogeny enabled us to assign >95% of our reads to order level and ~85% to genus level despite the presence of a large, hitherto unknown diversity. Over 40% of the annotated sequences were assigned to Glissomonad genera, whereas the most common individually named genus was the euglyphid Trinema. Cercozoan diversity was largely resilient to drought, although we observed a community composition shift towards fewer testate amoebae

Towards diagnostic metagenomics of Campylobacter in fecal samples

Abstract Background The development of diagnostic metagenomics is driven by the need for universal, culture-independent methods for detection and characterization of pathogens to substitute the time-consuming, organism-specific, and often culture-based laboratory procedures for epidemiological source-tracing. Some of the challenges in diagnostic metagenomics are, that it requires a great next-generation sequencing depth and unautomated data analysis. Results DNA from human fecal samples spiked with 7.75 × 101−7.75 × 107 colony forming unit (CFU)/ml Campylobacter jejuni and chicken fecal samples spiked with 1 × 102–1 × 106 CFU/g Campylobacter jejuni was sequenced and data analysis was done by the metagenomic tools Kraken and CLARK. More hits were obtained at higher spiking levels, however with no significant linear correlations (human samples p = 0.12, chicken samples p = 0.10). Therefore, no definite detection limit could be determined, but the lowest spiking levels found positive were 7.75 × 104 CFU/ml in human feces and 103 CFU/g in chicken feces. Eight human clinical fecal samples with estimated Campylobacter infection loads from 9.2 × 104–1.0 × 109 CFU/ml were analyzed using the same methods. It was possible to detect Campylobacter in all the clinical samples. Conclusions Sensitivity in diagnostic metagenomics is improving and has reached a clinically relevant level. There are still challenges to overcome before real-time diagnostic metagenomics can replace quantitative polymerase chain reaction (qPCR) or culture-based surveillance and diagnostics, but it is a promising new technology

Comparative retention and effectiveness of migraine preventive treatments: A nationwide registry-based cohort study

Background and purpose Little is known about the comparative effects of migraine preventive drugs. We aimed to estimate treatment retention and effectiveness of migraine preventive drugs in a nationwide registry-based cohort study in Norway between 2010 and 2020. Methods We assessed retention, defined as the number of uninterrupted treatment days, and effectiveness, defined as the reduction in filled triptan prescriptions during four 90-day periods after the first preventive prescription, compared to a 90-day baseline period. We compared retention and efficacy for different drugs against beta blockers. Comparative retention was estimated with hazard ratios (HRs), adjusted for covariates, using Cox regression, and effectiveness as odds ratios (ORs) using logistic regression, with propensity-weighted adjustment for covariates. Results We identified 104,072 migraine patients, 81,890 of whom were female (78.69%) and whose mean (standard deviation) age was 44.60 (15.61) years. Compared to beta blockers, botulinum toxin (HR 0.43, 95% confidence interval [CI] 0.42–0.44) and calcitonin gene-related peptide pathway antibodies (CGRPabs; HR 0.63, 95% CI 0.59–0.66) were the least likely to be discontinued, while clonidine (HR 2.95, 95% CI 2.88–3.02) and topiramate (HR 1.34, 95% CI 1.31–1.37) were the most likely to be discontinued. Patients on simvastatin, CGRPabs, and amitriptyline were more likely to achieve a clinically significant reduction in triptan use during the first 90 days of treatment, with propensity score-adjusted ORs of 1.28 (95% CI 1.19–1.38), 1.23 (95% CI 0.79–1.90), and 1.13 (95% CI 1.08–1.17), respectively. Conclusions We found a favorable effect of CGRPabs, amitriptyline, and simvastatin compared with beta blockers, while topiramate and clonidine were associated with poorer outcomes.publishedVersio

In vitro evidence of root colonization suggests ecological versatility in the genus Mycena

Acknowledgements: The European commission is acknowledged for a MSCA grant to C.B.H (grant no. 658849), the University of Oslo for further funding of the project, and the Swedish University of Agricultural Sciences for hosting parts of the experiments. C.B.H was funded by an internationalisation grant from the Carlsberg Research Grant Foundation at the time of writing (grant no. CF18-0809). We would like to thank Jerome Guerrand for aid in in vitro laboratory techniques, the Norwegian Forest Seed Center for provision of seeds, Hedda Weitz and Tatiana A. Semenova-Nelson and Taina Pennanen for provision of fungal cultures. We would like to thank Marc-André Selosse, Peter Kennedy and four anonymous referees for valuable comments to an earlier version of this manuscript.Peer reviewedPublisher PD

Detection of Active Matriptase using a Biotinylated Chloromethyl Ketone Peptide

Matriptase is a member of the family of type II transmembrane serine proteases that is essential for development and maintenance of several epithelial tissues. Matriptase is synthesized as a single-chain zymogen precursor that is processed into a two-chain disulfide-linked form dependent on its own catalytic activity leading to the hypothesis that matriptase functions at the pinnacle of several protease induced signal cascades. Matriptase is usually found in either its zymogen form or in a complex with its cognate inhibitor hepatocyte growth factor activator inhibitor 1 (HAI-1), whereas the active non-inhibited form has been difficult to detect. In this study, we have developed an assay to detect enzymatically active non-inhibitor-complexed matriptase by using a biotinylated peptide substrate-based chloromethyl ketone (CMK) inhibitor. Covalently CMK peptide-bound matriptase is detected by streptavidin pull-down and subsequent analysis by Western blotting. This study presents a novel assay for detection of enzymatically active matriptase in living human and murine cells. The assay can be applied to a variety of cell systems and species

Mycena species can be opportunist-generalist plant root invaders

ACKNOWLEDGEMENTS We thank Karl-Henrik Larsson and Arne Aronsen for provisions of specimens from the Natural History Museum of Oslo and help with the identification of field specimens from Svalbard. We further thank Cecilie Mathiesen and Mikayla Jacobs for technical assistance in the laboratory, Brendan J. Furneaux for valuable input to the R script, and the curators of H, TUR, and OULU. The Mycena ITS sequences originating from the specimens deposited in H, TUR, and OULU were produced as part of the Finnish Barcode of Life Project (FinBOL) funded by the Ministry of Environment, Finland (YM23/5512/2013), Otto A Malm's Donationsfond, and the Kone Foundation. We thank the European Commission (grant no. 658849) and the Carlsberg Foundation (grant no. CF18-0809) for grants to C.B. Harder that made this research possible. C.B. Harder was financed by a grant from the Danish Independent Research Fund DFF/FNU 2032-00064B (SapMyc) at the time of writing. Research Funding Carlsbergfondet. Grant Number: CF18-0809 Danish Independent Research Fund. Grant Number: 2032-00064B European Commission. Grant Number: 658849 Ministry of Environment, Finland. Grant Number: YM23/5512/2013Peer reviewedPublisher PD

Real world evidence in priority setting and health care planning: an application on the cost of cancer

The overall aim of this thesis is to explore how real-world evidence can be used to support priority setting and planning in the cancer care. The thesis includes four published papers in which data from Norwegian health registries are used to study management of cancer, resource use and costs. In Paper 1, health care costs are estimated to NOK 21 billion, while lost productivity and the value of lost health amount to NOK 28 and 180 billion, respectively. The results from Paper II indicate that the treatment costs are highest during the initial treatment phase and in the terminal phase. Paper III examines the use of anti-cancer drugs end-of-life and provide evidence that fewer patients receive such treatment in Norway compared with other countries. The analyses in Paper IV shows that most of the gender differences in treatment costs end-of-life can be explained by differences in the type of cancer, age, and place of death. The four included papers demonstrate in various ways how real-world evidence can support health economic analyzes, which can provide information to support efficient and fair distribution of resources